1. Home
  2. IBRX vs EXK Comparison

IBRX vs EXK Comparison

Compare IBRX & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$2.32

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Endeavour Silver Corporation (Canada)

EXK

Endeavour Silver Corporation (Canada)

HOLD

Current Price

$9.91

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
EXK
Founded
2014
1981
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IBRX
EXK
Price
$2.32
$9.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
4
Target Price
$9.83
$11.69
AVG Volume (30 Days)
9.5M
10.5M
Earning Date
11-04-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$82,555,000.00
$337,137,000.00
Revenue This Year
$629.94
$100.51
Revenue Next Year
$109.91
$79.58
P/E Ratio
N/A
N/A
Revenue Growth
1025.95
49.22
52 Week Low
$1.83
$2.95
52 Week High
$5.16
$10.37

Technical Indicators

Market Signals
Indicator
IBRX
EXK
Relative Strength Index (RSI) 58.44 70.00
Support Level $2.05 $6.91
Resistance Level $2.18 $7.97
Average True Range (ATR) 0.13 0.58
MACD 0.03 0.18
Stochastic Oscillator 83.00 95.99

Price Performance

Historical Comparison
IBRX
EXK

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About EXK Endeavour Silver Corporation (Canada)

Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.

Share on Social Networks: